EUPRAXIA PHARMACEUTICALS INC. of VICTORIA, A1, a company, filed a Form D exempt-offering notice with the SEC on 2024-11-08. The offering totals $1.9M, of which $1.9M was reported sold. Industry: Biotechnology.
Showing 25 of 26 people.
| Name | Role | Location |
|---|---|---|
| Joseph Freedman | Director | VENICE, CA |
| Paul Geyer | Director | Victoria, A1 |
| Richard Glickman | Director | Victoria, A1 |
| James Helliwell | Director | Victoria, A1 |
| John Montalbano | Director | Victoria, A1 |
| Simon Pimstone | Director | Victoria, A1 |
| Michael Wilmink | Director | Victoria, A1 |
| Paul Brennan | Executive Officer | Oxford, X0 |
| Bruce Cousins | Executive Officer | Victoria, A1 |
| James Helliwell | Executive Officer | Victoria, A1 |
| Mark Kowalski | Executive Officer | Victoria, A1 |
| Amanda Malone | Executive Officer | Victoria, A1 |
| Rahul Sarugaser | Executive Officer | Victoria, A1 |
| Bruce A Cousins | Executive Officer | Victoria, A1 |
| Mark A Kowalski | Executive Officer | Victoria, A1 |
| Paul A Geyer | Director | Victoria, A1 |
| John A Montalbano | Director | Victoria, A1 |
| Simon A Pimstone | Director | Victoria, A1 |
| James A Helliwell | Director | Victoria, A1 |
| James A Helliwell | Executive Officer | Victoria, A1 |
| Michael A Wilmink | Director | Victoria, A1 |
| Richard A Glickman | Director | Victoria, A1 |
| Paul A Brennan | Executive Officer | Victoria, A1 |
| Amanda A Malone | Executive Officer | Victoria, A1 |
| David Stadnyk | Director | Vancouver, A1 |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2023-08-22 | D | $128K | $128K |
| 2016-04-18 | D | $38K | $38K |
| 2013-09-16 | D | $24K | $24K |
| 2013-07-11 | D | $24K | $24K |
| 2013-07-11 | D | $645K | $377K |
| 2013-07-11 | D | $13K | $5K |
| 2013-07-11 | D | $10K | $10K |